BioProject,Run,EV_type,Source,disease,Disease_stage/treatment,Release_date,URL,EV isolated method,Project_Title,Project_Description
PRJNA792027,SRR17326410,sEV,Bone marrow|Primary cell|human bone marrow mesenchymal stem cell,Healthy donor,-,2021-12-24,https://pubmed.ncbi.nlm.nih.gov/37305542/,"The isolated EVs were characterized for number and size distribution and presence of membrane markers by nano tracking analysis (NTA) and immunoblotting. For NTA, a 1/100 dilution of the EV suspension was analyzed in the Nanosight NS-300 instrument to obtain the average number of particles and the size distribution plot. Based on the NTA results, approximately equal concentration of control and TNFÎ± EVs (1.8x1010 particles/ml) were used for each experiment.",human Bone marrow mesenchymal stem cell-derived small extracellular vesicles miRNA sequencing,human Bone marrow mesenchymal stem cell-derived small extracellular vesicles miRNA sequencing
